See What HealthDay Can Do For You
Contact Us

Stop-Smoking Program Effective in Psychotic Patients

Program increased rates of smoking cessation, smoking reduction

THURSDAY, Nov. 2 (HealthDay News) -- A stop-smoking program is effective for smoking cessation and smoking reduction in individuals with a psychotic disorder, according to the results of a study published in the November issue of the American Journal of Psychiatry.

Amanda Baker, Ph.D., from the University of Newcastle in Callaghan, Australia, and colleagues examined the effectiveness of a smoking-cessation program in 298 regular smokers with a psychotic disorder. Patients were randomly assigned to either routine care or an eight-week stop-smoking program consisting of nicotine replacement therapy, cognitive behavior therapy and motivational interviewing.

The researchers found that significantly more patients who completed the smoking-cessation program had stopped smoking after three months (30 percent versus 6 percent), which continued for up to 12 months (18.6 percent versus 6.6 percent). The program also led to a reduction of at least 50 percent in daily cigarette consumption compared with a less than 20 percent reduction in those in the routine care group.

"These findings demonstrate the utility of a nicotine replacement therapy plus motivational interviewing/cognitive behavior therapy smoking cessation intervention among individuals with a psychotic disorder," the authors conclude.

GlaxoSmithKline provided nicotine replacement therapy for the study.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing